Corporate Banner
Satellite Banner
Scientific Community
Become a Member | Sign in
Home>News>This Article

SARomics Biostructures Brings in New Strategic Owners

Published: Saturday, September 15, 2012
Last Updated: Saturday, September 15, 2012
Bookmark and Share
Innovationsbron AB and LUIS AB are investing in and becoming new co-owners of the company.

SARomics Biostructures AB has announced that Innovationsbron AB and Lund University Innovation System AB (LUIS AB) are investing in and becoming new co-owners of the company alongside the founders.

The new investment will allow the company to expand its primary business of generating 3D structural information of proteins and protein-ligand complexes.

SARomics Biostructures is a major user of MAX-lab, the Swedish national synchrotron facility in Lund, and aims to position itself as a leading European structural biology service provider when the new world-class MAX IV synchrotron opens in 2015.

Linus Wiebe, CEO of LUIS said “SARomics Biostructures has shown the commercial potential of MAX-lab and we believe that our strategic investment will leverage the company to take full advantage of MAX IV in the future.”

SARomics Biostructures gene-to-structure platform has successfully been applied to determine structures of many important drug targets, biopharmaceuticals, and industrial enzymes for partners from both the life science industry and academia worldwide.

The company is currently expanding its off-the-shelf portfolio of “ready made” crystal structures of important drug targets and will also engage in internal lead discovery programs.

Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More than 5,200+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

SARomics Biostructures and Xbrane Bioscience Form a Strategic Partnership
Strategic partnership to deliver “off-the-shelf” protein structure services.
Thursday, January 30, 2014
A New EU-Funded Industry-Academia Drug Discovery Partnership Targets Challenging Kinases
Industry and academia join to create the Translational Kinase Tumor Inhibitor Discovery Consortium.
Wednesday, April 10, 2013
SARomics Biostructures and Red Glead Discovery Enters into Drug Discovery Collaboration
The companies will perform a joint collaborative project with the goal of developing novel lead compounds against epigenetic pathway targets.
Thursday, October 25, 2012
Scientific News
Step Toward Controlling Zika and Dengue Fever
UCLA scientists and colleagues identify structure of a molecule that kills mosquitoes carrying malaria and West Nile virus.
Uncovering Bacteria's Antibiotic Resistance
Scientists determine the structure and mechanisms of enzyme that deactivates an important antibiotic - rifampicin.
Diamond Light Source Scientists Publish 5000th Paper
Diamond’s milestone paper reveals findings on embryonic defects.
3D-Printing in Science: Conference Co-Staged with LABVOLUTION
LABVOLUTION 2017 will have an added highlight of a simultaneous conference, "3D-Printing in Science".
Cone Snail Venom Reveals Insulin Insights
Researchers found that a fast-acting insulin from the cone snail can bind and activate the human insulin receptor.
Protein Studies Discover Molecular Secrets
Two protein studies have mapped proteins that reveal the secrets to recycling carbon and healing cells.
Designing Drugs with a Whole New Toolbox
Researchers develop methods to design small, targeted proteins with shapes not found in nature.
Antibodies Block Norovirus’ Entrance into Cells
Scientists have uncovered a mechanism in the human body that targets and successfully blocks noroviruses.
Protein Findings Could Lead To New Class Of Antibiotics
Atomic-level images of a protein have revealed a characteristic that could form a basis of new antibiotic approach.
Worms Point Way Toward Viral Strategies
Rice University wins NIH grant to study how nematodes handle gastrointestinal viruses.

SELECTBIO Market Reports
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,200+ scientific videos